Edition:
United Kingdom

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

6,366.45INR
15 Dec 2017
Change (% chg)

Rs82.30 (+1.31%)
Prev Close
Rs6,284.15
Open
Rs6,289.00
Day's High
Rs6,397.75
Day's Low
Rs6,225.80
Volume
20,188
Avg. Vol
10,223
52-wk High
Rs6,397.75
52-wk Low
Rs4,851.00

Chart for

About

GlaxoSmithKline Consumer Healthcare Limited is a food processing company. The Company offers malt-based food, protein rich food, cereal-based beverage and nutritional food powder. Its products include nutritional products and over the counter (OTC) products. The Company's nutritional products include Horlicks Ninja, Junior... (more)

Overall

Beta: 0.72
Market Cap(Mil.): Rs210,178.91
Shares Outstanding(Mil.): 42.06
Dividend: 70.00
Yield (%): 1.40

Financials

  Industry Sector
P/E (TTM): -- 22.52 16.44
EPS (TTM): -- -- --
ROI: -- 12.31 10.62
ROE: -- 15.70 14.20

BRIEF-India's Glaxosmithkline Consumer Healthcare Sept qtr profit up about 4 pct

* Sept quarter net profit 1.92 billion rupees versus profit of 1.84 billion rupees last year

07 Nov 2017

REFILE-Morning News Call - India, November 7

(Corrects to remove item on GlaxoSmithKline Consumer Healthcare post-earnings analyst conference call as the event is slated for Nov 8) To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_11072017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 9:30 am: GMR Group CFO Madhu Terdal, NHAI Member Rohit Kumar Singh

07 Nov 2017

BRIEF-Glaxosmithkline Consumer's board accepts resignation of formerly executive director

* SAYS BOARD ACCEPTS RESIGNATION OF PUNEET SHARMA FORMERLY EXECUTIVE DIRECTOR, WITH EFFECT FROM JULY 14, 2017

28 Jul 2017

BRIEF-Glaxosmithkline Consumer Nigeria posts HY group pre-tax profit 31.5 mln naira

* HY ENDED JUNE 2017 GROUP PROFIT BEFORE TAX 31.5 MILLION NAIRA VERSUS LOSS OF 1.13 BILLION NAIRA

28 Jul 2017

Earnings vs. Estimates